Építés alatt – nem éles oldal
Belépés

1-es típusú cukorbetegség trials, also abroad

608 open 1-es típusú cukorbetegség trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Egyesült Államok217
Kanada52
Franciaország43
Kína40
Dánia35
All other countries

The same trial often runs in several countries

Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration? has 1 site in Katar and runs in 3 countries. If a site near you is full, another one may still take people.

See Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration? in all 3 countries